Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.
News | Cardiovascular Clinical Studies
Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump

September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...

Home September 06, 2023
Home
GE HealthCare and Mass General Brigham have announced the co-development of an artificial intelligence (AI) algorithm that will help increase operations effectiveness and productivity.
News | Artificial Intelligence
Mass Gen Brigham and GE HealthCare Collaboration Announces AI Algorithm, Radiology Operations Module (ROM), to Optimize Scheduling and Productivity

September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co ...

Home September 06, 2023
Home
Results from Two Phase 3 studies evaluating CAMZYOS (mavacamten) for symptomatic obstructive hypertrophic cardiomyopathy (HCM) were recently released by Bristol Myers Squibb.
News | Cardiovascular Clinical Studies
Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

September 5, 2023 — New long-term follow-up results from two Phase 3 studies evaluating CAMZYOS (mavacamten), a first-in ...

Home September 05, 2023
Home
News | Cardiac Diagnostics
Wireless Handheld Ultrasound Device Launched by GE HealthCare for Rapid Assessment of Cardiac and Vascular Patients

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Raj Makkar, MD
News | Heart Failure
Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe

September 5, 2023 — Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve ...

Home September 05, 2023
Home
The Ohio State University Wexner Medical Center randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
News | Cardiovascular Clinical Studies
Ohio State First in World to Participate in Trial of Device Designed to Alleviate Heart Failure Symptoms

September 5, 2023 — The Ohio State University Wexner Medical Center randomized the first patient in the world in a ...

Home September 05, 2023
Home
First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
News | Stents Bioresorbable
BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK’s Newest Resorbable Magnesium Scaffold Resorbed at 12 Months

September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process following ...

Home September 05, 2023
Home
CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023
News | Atrial Fibrillation
Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure

August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or ...

Home August 31, 2023
Home
ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023
News | Cardiovascular Clinical Studies
ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support

August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial ...

Home August 31, 2023
Home
This is the first international guideline document to include all cardiomyopathy subtypes
News | Congenital Heart
First International Guidelines on Heart Muscle Diseases Published

August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in ...

Home August 31, 2023
Home
Here's a look at what viewers found most interesting during the month of August on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: A Look at the Hot Topics from August

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home August 31, 2023
Home
Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023
News | Cardiovascular Clinical Studies
12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ...

Home August 30, 2023
Home
MULTISTARS AMI trial presented in a Hot Line session today at ESC Congress 2023
News | Cardiovascular Clinical Studies
Trial Investigates Timing of Complete Revascularization for Myocardial Infarction

August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel ...

Home August 30, 2023
Home
News | Heart Failure
Highlights from the ESC Congress 2023

August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said ...

Home August 30, 2023
Home
Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session at ESC Congress 2023
News | Optical Coherence Tomography (OCT)
Optical Coherence Tomography Non-inferior to Intravascular Ultrasound for Stent Guidance

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...

Home August 29, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now